Arkray USA launches "new, improved" version of glucose monitoring test strips
This article was originally published in Clinica
Arkray USA has launched a "new and improved" Assure Pro blood glucose monitoring test strip. The new product requires 0.5 microlitres of blood, compared with 1 microlitre with the previous version. It also exceeds the US FDA's proposed increased accuracy guidelines, the Edina, Minnesota-based division of the Japanese diagnostics firm claims. In a recent study, 100% of results fall within 15% of those from a lab test, and 98% fall within 10%. The Assure Pro blood glucose monitoring system is designed for long-term care and multi-resident settings.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.